TRULIEVE CANNABIS CORP. Selling and Marketing Expense
TRULIEVE CANNABIS CORP. (TRLV) reported Selling and Marketing Expense of $257.72 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2025-02-27
- TRULIEVE CANNABIS CORP. selling and marketing expense for the quarter ending 2024-12-31 was $66.70M, a 13.13% increase year-over-year.
- TRULIEVE CANNABIS CORP. selling and marketing expense for the quarter ending 2024-09-30 was $66.73M, a 12.34% increase year-over-year.
- TRULIEVE CANNABIS CORP. selling and marketing expense for the quarter ending 2024-06-30 was $63.18M, a 3.45% increase year-over-year.
- TRULIEVE CANNABIS CORP. selling and marketing expense for the quarter ending 2024-03-31 was $61.11M, a 0.62% increase year-over-year.
- TRULIEVE CANNABIS CORP. selling and marketing expense for fiscal 2024 was $257.72M, a 7.31% increase from fiscal 2023.
- TRULIEVE CANNABIS CORP. selling and marketing expense for fiscal 2023 was $240.16M, a 13.47% decline from fiscal 2022.
- TRULIEVE CANNABIS CORP. selling and marketing expense for fiscal 2022 was $277.56M, a 30.98% increase from fiscal 2021.
- TRULIEVE CANNABIS CORP. selling and marketing expense for fiscal 2021 was $211.91M, a 77.48% increase from fiscal 2020.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 3 month as first filed | Selling and Marketing Expense 6 month | Selling and Marketing Expense 6 month as first filed | Selling and Marketing Expense 9 month | Selling and Marketing Expense 9 month as first filed | Selling and Marketing Expense 12 month | Selling and Marketing Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | $66.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $133.43M derived: sum of 2 quarters · filed 2025-02-27 | $196.61M derived: sum of 3 quarters · filed 2025-02-27 | $257.72M 10-K · filed 2025-02-27 | ||||
| 2024-09-30 | $66.73M 10-Q · filed 2024-11-05 | $129.91M derived: sum of 2 quarters · filed 2024-11-05 | $191.02M 10-Q · filed 2024-11-05 | $249.97M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2024-06-30 | $63.18M 10-Q · filed 2024-08-06 | $124.29M 10-Q · filed 2024-08-06 | $183.25M derived: sum of 3 quarters · filed 2025-02-27 | $242.65M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2024-03-31 | $61.11M 10-Q · filed 2024-05-09 | $120.07M derived: sum of 2 quarters · filed 2025-02-27 | $179.46M derived: sum of 3 quarters · filed 2025-02-27 | $240.54M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-12-31 | $58.96M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $118.36M derived: sum of 2 quarters · filed 2025-02-27 | $179.43M derived: sum of 3 quarters · filed 2025-02-27 | $240.16M 10-K · filed 2025-02-27 | ||||
| 2023-09-30 | $59.40M 10-Q · filed 2024-11-05 | $120.47M derived: sum of 2 quarters · filed 2024-11-05 | $181.21M 10-Q · filed 2024-11-05 | $239.09M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-06-30 | $61.08M 10-Q · filed 2024-08-06 | $121.81M 10-Q · filed 2024-08-06 | $179.69M derived: sum of 3 quarters · filed 2025-02-27 | $254.02M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-03-31 | $60.73M 10-Q · filed 2024-05-09 | $62.31M 10-Q · filed 2023-05-10 | $118.62M derived: sum of 2 quarters · filed 2025-02-27 | $192.94M derived: sum of 3 quarters · filed 2025-02-27 | $266.85M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2022-12-31 | $57.88M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $132.21M derived: sum of 2 quarters · filed 2025-02-27 | $206.11M derived: sum of 3 quarters · filed 2025-02-27 | $277.56M 10-K · filed 2025-02-27 | $284.94M 10-K · filed 2023-03-08 | |||
| 2022-09-30 | $74.33M 10-Q · filed 2023-11-09 | $75.92M 10-Q · filed 2022-11-09 | $148.23M derived: sum of 2 quarters · filed 2023-11-09 | $219.68M 10-Q · filed 2023-11-09 | $224.03M 10-Q · filed 2022-11-09 | $290.11M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-06-30 | $73.90M 10-Q · filed 2023-08-09 | $75.29M 10-Q · filed 2022-08-10 | $145.35M 10-Q · filed 2023-08-09 | $148.15M 10-Q · filed 2022-08-10 | $215.79M derived: sum of 3 quarters · filed 2024-02-29 | $267.51M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-03-31 | $72.84M 10-Q · filed 2023-05-10 | $72.86M 10-Q · filed 2022-05-12 | $141.88M derived: sum of 2 quarters · filed 2024-02-29 | $193.61M derived: sum of 3 quarters · filed 2024-02-29 | $240.19M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2021-12-31 | $69.05M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $120.77M derived: sum of 2 quarters · filed 2024-02-29 | $167.35M derived: sum of 3 quarters · filed 2024-02-29 | $211.91M 10-K · filed 2024-02-29 | $215.14M 10-K · filed 2022-03-30 | |||
| 2021-09-30 | $51.72M 10-Q · filed 2022-11-09 | $98.30M derived: sum of 2 quarters · filed 2022-11-09 | $142.86M 10-Q · filed 2022-11-09 | $181.49M derived: sum of 4 quarters · filed 2023-04-05 | ||||
| 2021-06-30 | $46.58M 10-Q · filed 2022-08-10 | $91.14M 10-Q · filed 2022-08-10 | $129.76M derived: sum of 3 quarters · filed 2023-04-05 | $160.66M derived: sum of 4 quarters · filed 2023-04-05 | ||||
| 2021-03-31 | $44.56M 10-Q · filed 2022-05-12 | $83.19M derived: sum of 2 quarters · filed 2023-04-05 | $114.08M derived: sum of 3 quarters · filed 2023-04-05 | $141.09M derived: sum of 4 quarters · filed 2023-04-05 | ||||
| 2020-12-31 | $38.63M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-04-05 | $69.52M derived: sum of 2 quarters · filed 2023-04-05 | $96.53M derived: sum of 3 quarters · filed 2023-04-05 | $119.39M 10-K/A · filed 2023-04-05 | ||||
| 2020-09-30 | $30.89M 10-Q · filed 2021-11-15 | $57.90M derived: sum of 2 quarters · filed 2021-11-15 | $80.76M 10-Q · filed 2021-11-15 | |||||
| 2020-06-30 | $27.01M 10-Q · filed 2021-08-12 | $49.87M 10-Q · filed 2021-08-12 | ||||||
| 2020-03-31 | $22.87M 10-Q · filed 2021-05-13 | |||||||
| 2019-12-31 | $59.35M 10-K/A · filed 2023-04-05 |